How Will Rescheduling of Hydrocodone Combo Products Affect Your Practice?

On Oct. 6, the DEA will move hydrocodone combination products from Schedule III to Schedule II, so family physicians need to prepare their practices -- and their patients -- for the change.
Source: AAFP News - Category: Primary Care Source Type: news